|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Salarius Pharmaceuticals, Inc (SLRX) |
|
|
$0.61 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
2,280,000 |
Market
Cap: |
1.38(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.6068 - $0.6068 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s pipeline consists of two compounds: seclidemstat (SP-2577), a small molecular inhibitor and SP-3164, a small molecular protein degrader. SP-2577 is a small-molecule lysine specific demethylase 1 (LSD1) inhibitor with a scaffold. LSD1 is an enzyme that is, in part, responsible for epigenetic regulation of genes that support cancer growth. SP-3164 is a cereblon binding molecular glue. SP-3164 degrades transcription factors IKZF1 and IKZF3, along with other proteins, resulting in both direct anti-cancer activity and immune-modulating properties. SP-3164 has activity in both hematologic and solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
191,653 |
Total Buy Value |
$0 |
$0 |
$0 |
$35,178 |
Total People Bought |
0 |
0 |
0 |
6 |
Total Buy Transactions |
0 |
0 |
0 |
7 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sculley John |
Director |
|
2016-03-18 |
4 |
B |
$11.13 |
$7,891 |
I/I |
709 |
709 |
2.1 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-03-18 |
4 |
B |
$11.06 |
$203,913 |
I/I |
18,437 |
2,862,897 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-03-17 |
4 |
B |
$10.94 |
$209,359 |
I/I |
19,137 |
2,844,460 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-03-16 |
4 |
B |
$10.85 |
$207,691 |
I/I |
19,142 |
2,825,323 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-03-15 |
4 |
B |
$9.62 |
$185,060 |
I/I |
19,237 |
2,806,181 |
2.64 |
- |
|
Stacy Michelle |
Director |
|
2016-03-15 |
4 |
B |
$9.63 |
$24,894 |
D/D |
2,585 |
2,585 |
2.39 |
- |
|
Wessel Thomas |
Chief Medical Officer |
|
2016-03-14 |
4 |
B |
$9.13 |
$73,040 |
D/D |
8,000 |
57,064 |
2.74 |
- |
|
Wessel Thomas |
Chief Medical Officer |
|
2016-03-11 |
4 |
B |
$7.15 |
$85,800 |
D/D |
12,000 |
49,064 |
2.74 |
- |
|
Mackinnon Roderick |
Director |
|
2016-03-11 |
4 |
B |
$7.03 |
$70,261 |
D/D |
10,000 |
431,277 |
2.39 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-03-11 |
4 |
B |
$7.00 |
$627,760 |
I/I |
89,680 |
2,786,944 |
2.64 |
- |
|
Longwood Fund Ii, L.p. |
10% Owner |
|
2016-03-11 |
4 |
B |
$7.00 |
$627,760 |
D/D |
89,680 |
2,786,944 |
2.45 |
- |
|
Westphal Christoph H |
President and CEO |
|
2015-12-14 |
4 |
AB |
$12.01 |
$11,130 |
D/D |
927 |
3,925,248 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-12-07 |
4 |
AB |
$12.02 |
$10,899 |
D/D |
907 |
3,924,321 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-11-30 |
4 |
AB |
$12.32 |
$10,929 |
D/D |
887 |
3,923,414 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-11-23 |
4 |
AB |
$11.39 |
$11,064 |
D/D |
971 |
3,922,527 |
|
- |
|
Kozin Marc D |
Director |
|
2015-11-19 |
4 |
B |
$11.38 |
$51,219 |
D/D |
4,500 |
4,500 |
2.39 |
- |
|
Westphal Christoph H |
President and CEO |
|
2015-11-16 |
4 |
AB |
$10.78 |
$10,791 |
D/D |
1,001 |
3,921,556 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-11-09 |
4 |
AB |
$11.03 |
$11,032 |
D/D |
1,000 |
3,920,555 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-11-02 |
4 |
AB |
$11.59 |
$11,204 |
D/D |
967 |
3,919,555 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-10-26 |
4 |
AB |
$10.55 |
$11,003 |
D/D |
1,043 |
3,918,588 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-10-19 |
4 |
AB |
$10.61 |
$10,797 |
D/D |
1,018 |
3,917,545 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-10-12 |
4 |
AB |
$11.98 |
$11,072 |
D/D |
924 |
3,916,527 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-10-05 |
4 |
AB |
$12.48 |
$10,833 |
D/D |
868 |
3,915,603 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-09-28 |
4 |
AB |
$11.18 |
$10,335 |
D/D |
924 |
3,914,735 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2015-09-21 |
4 |
AB |
$16.04 |
$11,757 |
D/D |
733 |
3,913,811 |
|
- |
|
156 Records found
|
|
Page 5 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|